Fetal Vascular Hemodynamic Changes in Iron Deficiency Anemia

Fetal Vascular Hemodynamic Changes Before and After Treatment of Maternal Iron Deficiency Anemia

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03883841

Enrollment

Registered

2019-03-21

Start date

2019-05-31

Completion date

2020-10-31

Last updated

2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency Anemia

Brief summary

Iron deficiency anemia is a worldwide medical disorder. So far, it is the most common medical complication in pregnancy specially in developing countries. It is the cause of many adverse effects on mother and fetus and contributes significantly to high maternal mortality. Maternal iron deficiency anemia is frequently associated with premature delivery, low birth weight babies

Interventions

DRUGIron Sucrose Solution for Injection

intravenous infusion of iron sucrose

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Pregnant women with gestational age 28-32 weeks * singleton pregnancy * iron deficiency anemia.

Exclusion criteria

* Multiple pregnancy * antepartum hemorrhage * major congenital fetal anomalies * any other type of anemia other than iron deficiency anemia * any acute or chronic maternal disease other than iron deficiency anemia.

Design outcomes

Primary

Measure	Time frame	Description
The mean changes in middle cerebral artery Doppler of the fetus	one month	Doppler evaluation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026